Results 21 to 30 of about 978 (138)
Carbon ion radiotherapy for recurrent calf myxoid liposarcoma: a case report
Liposarcoma (LPS) is the most common soft tissue sarcoma. Myxoid LPS (MLPS) is the second most common subtype of LPS and accounts for 25% to 50% of all LPSs.
Xiaojun Li +9 more
doaj +1 more source
Real-time energy measurement of clinical carbon ion beams using a cross-correlation time-of-flight method with parallel-plate chambers. [PDF]
Abstract Background In carbon‐ion radiotherapy (CIRT), the beam energy determines both the particle range and the overall dosimetric quality. Range‐verification QA devices such as Zebra and Giraffe, which are based on multilayer ionization chambers (MLICs), can verify the range but only under dedicated QA conditions, leaving any energy deviations ...
Kwon NH +15 more
europepmc +2 more sources
A preliminary study on effect of carbon ion radiotherapy on bone marrow suppression
Objective: To explore the effect of carbon ion radiotherapy (CIRT) on the bone marrow adjacent to or within the treatment fields, and to observe the bone marrow toxicities after CIRT alone.
Ying Qi +9 more
doaj +1 more source
Background Concurrent chemoradiotherapy has been standard of care for unresectable esophageal carcinoma. There were no reports on proton radiotherapy (PRT) plus carbon-ion radiotherapy (CIRT) with pencil beam scanning (PBS) for esophageal carcinoma. This
Ningyi Ma +6 more
doaj +1 more source
Carbon ion radiotherapy for prostate cancer with bladder invasion
Background The optimal management of clinical T4 (cT4) prostate cancer (PC) is still uncertain. At our institution, carbon ion radiotherapy (CIRT) for nonmetastatic PC, including tumors invading the bladder, has been performed since 2010.
Yuhei Miyasaka +10 more
doaj +1 more source
The Majority of United States Citizens With Cancer do not Have Access to Carbon Ion Radiotherapy
As of December 31, 2020, there were 12 facilities located in Asia and Europe which were treating cancer patients with carbon ion radiotherapy (CIRT). Between June 1994 and December 2020, 37,548 patients were treated with CIRT worldwide.
Robert L. Foote +9 more
doaj +1 more source
Application of intrahepatic fiducial markers in carbon ion radiotherapy for pancreatic cancer-Achieving higher precision treatment. [PDF]
Abstract Background Carbon‐ion radiotherapy (CIRT) delivers highly conformal tumor doses while sparing surrounding organs‐at‐risk (OAR). However, density variations along the beam path and interfractional target motion can reduce target coverage and expose OAR to high doses.
Nagata J +9 more
europepmc +2 more sources
Introduction: Spinal malignant peripheral nerve sheath tumors (MPNSTs) are extremely rare. Because of vital surroundings, en bloc resection can be difficult in MPNSTs of the cervical spine.
Akira Honda +10 more
doaj +1 more source
Carbon ion radiotherapy (CIRT) has garnered interest for the treatment of locoregional rectal cancer recurrence. No study has compared CIRT and X-ray radiotherapy (XRT) for reirradiation (reRT) in such cases.
Seung Yeun Chung +7 more
doaj +1 more source
Carbon ion radiotherapy (CIRT) is an emerging type of radiotherapy for the treatment of solid tumors. In recent years, evidence accumulated that CIRT improves the therapeutic outcome in patients with otherwise poor response to immune checkpoint blockade.
Heng Zhou +11 more
doaj +1 more source

